For: | Visani M, Acquaviva G, De Leo A, Sanza V, Merlo L, Maloberti T, Brandes AA, Franceschi E, Di Battista M, Masetti M, Jovine E, Fiorino S, Pession A, Tallini G, de Biase D. Molecular alterations in pancreatic tumors. World J Gastroenterol 2021; 27(21): 2710-2726 [PMID: 34135550 DOI: 10.3748/wjg.v27.i21.2710] |
---|---|
URL: | https://www.wjgnet.com/1948-5190/full/v27/i21/2710.htm |
Number | Citing Articles |
1 |
Aditya V. Shreenivas, Shumei Kato, Jingjing Hu, Catherine Skefos, Jason Sicklick, Razelle Kurzrock. Carcinoma of unknown primary: Molecular tumor board‐based therapy. CA: A Cancer Journal for Clinicians 2022; 72(6): 510 doi: 10.3322/caac.21748
|
2 |
Deborah Malvi, Francesco Vasuri, Thais Maloberti, Viviana Sanza, Antonio De Leo, Adele Fornelli, Michele Masetti, Claudia Benini, Raffaele Lombardi, Maria Fortuna Offi, Mariacristina Di Marco, Matteo Ravaioli, Sirio Fiorino, Enrico Franceschi, Alba A. Brandes, Elio Jovine, Antonietta D’Errico, Giovanni Tallini, Dario de Biase. Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene Panel. Diagnostics 2022; 12(5): 1058 doi: 10.3390/diagnostics12051058
|
3 |
Julie Weigner, Raewyn Billings, Rodney J. Scott, Simon King. The utilisation of digital droplet PCR to enhance the diagnosis of bladder and pancreaticobiliary tumours in cytology specimens. Diagnostic Cytopathology 2023; 51(8): 511 doi: 10.1002/dc.25151
|
4 |
Carla Limeira Barreto, Cristiana de Lima Tavares, France Anne Reinaldo Maia, David Arruda Tavares de Queiroz Marques. Tumor de Frantz: relato de três casos. Journal Archives of Health 2024; 5(1): 260 doi: 10.46919/archv5n1-022
|
5 |
Rong Xia, Xiaoying Liu, Cristina H. Hajdu, Wenqing Cao, James N. Kaz, Tamas Gonda, Aylin Simsir. The utility of molecular studies on pancreatic cystic lesions: A comprehensive review. Human Pathology Reports 2024; 36: 300741 doi: 10.1016/j.hpr.2024.300741
|
6 |
Couvineau Alain, Nicole Pascal, Gratio Valérie, Voisin Thierry. Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target. Molecules 2021; 26(16): 4849 doi: 10.3390/molecules26164849
|
7 |
Miguel S. Gonzalez‐Mancera, Saman S. Ahmadian, Carmen Gomez‐Fernandez, Jaylou Velez‐Torres, Merce Jorda, Monica T. García‐Buitrago. Risk of malignancy associated with the diagnostic categories proposed by the Papanicolaou Society of Cytopathology for pancreaticobiliary specimens: An institutional experience. Diagnostic Cytopathology 2022; 50(2): 49 doi: 10.1002/dc.24910
|
8 |
Kai Li, Qian Wang, Hua Bian, Zhiguo Chen, Haifa He, Xulin Zhao, Pengju Gong. Comprehensive Analysis Reveals USP45 as a Novel Putative Oncogene in Pan-Cancer. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.886904
|
9 |
Rita Luis, Balamurugan Thirunavukkarasu, Deepali Jain, Sule Canberk. Welcoming the new, revisiting the old: a brief glance at cytopathology reporting systems for lung, pancreas, and thyroid. Journal of Pathology and Translational Medicine 2024; 58(4): 165 doi: 10.4132/jptm.2024.06.11
|
10 |
Alain Couvineau, Pascal Nicole, Valérie Gratio, Thierry Voisin. The Orexin receptors: Structural and anti-tumoral properties. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.931970
|
11 |
Antonio De Leo, Gloria Ravegnini, Francesco Musiani, Thais Maloberti, Michela Visani, Viviana Sanza, Sabrina Angelini, Anna Myriam Perrone, Pierandrea De Iaco, Angelo Gianluca Corradini, Francesca Rosini, Marco Grillini, Donatella Santini, Claudio Ceccarelli, Claudio Zamagni, Giovanni Tallini, Dario de Biase. Relevance of ARID1A Mutations in Endometrial Carcinomas. Diagnostics 2022; 12(3): 592 doi: 10.3390/diagnostics12030592
|
12 |
Luis Marti-Bonmati, Leonor Cerdá-Alberich, Alexandre Pérez-Girbés, Roberto Díaz Beveridge, Eva Montalvá Orón, Judith Pérez Rojas, Angel Alberich-Bayarri. Pancreatic cancer, radiomics and artificial intelligence. The British Journal of Radiology 2022; 95(1137) doi: 10.1259/bjr.20220072
|
13 |
Bo Franzén, Gert Auer, Rolf Lewensohn. Minimally invasive biopsy‐based diagnostics in support of precision cancer medicine. Molecular Oncology 2024; 18(11): 2612 doi: 10.1002/1878-0261.13640
|
14 |
Leonel Pekarek, Oscar Fraile‑Μartinez, Cielo Garcia‑Montero, Miguel Alvarez‑Mon, Julio Acero, Lidia Ruiz‑Llorente, Natalio García‑Honduvilla, Agustin Albillos, Julia Buján, Melchor Alvarez‑Mon, Luis Guijarro, Miguel Ortega. Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectives (Review). Oncology Letters 2021; 22(5) doi: 10.3892/ol.2021.13070
|
15 |
Shirin Hafezi, Maha Saber-Ayad, Wael M. Abdel-Rahman. Highlights on the Role of KRAS Mutations in Reshaping the Microenvironment of Pancreatic Adenocarcinoma. International Journal of Molecular Sciences 2021; 22(19): 10219 doi: 10.3390/ijms221910219
|
16 |
Akash Bararia, Amlan Das, Sangeeta Mitra, Sudeep Banerjee, Aniruddha Chatterjee, Nilabja Sikdar. Deoxyribonucleic acid methylation driven aberrations in pancreatic cancer-related pathways. World Journal of Gastrointestinal Oncology 2023; 15(9): 1505-1519 doi: 10.4251/wjgo.v15.i9.1505
Abstract(505) |
Core Tip(509) |
Full Article(HTML)(3138)
|
Full Article with Cover (PDF)-2302K(103)
|
Full Article (Word)-641K(52)
|
Audio-449K(3)
|
Peer-Review Report-207K(57)
|
Answering Reviewers-146K(61)
|
Full Article (PDF)-2009K(140)
|
Full Article (XML)-278K(61)
|
Times Cited (1)
|
Total Visits (6444)
|
Open
|